Psychedelic Medicine

After a 50 year freeze on psychedelics research, a new psychedelics renaissance is unfolding. As the field rapidly advances, we must continue to ask ethical questions about the safety, accessibility, legality, and public perceptions surrounding these drugs.

The ScattergoodEthics Program examines novel ethical issues in clinical research and treatment with psychedelic drugs such as informed consent, psychedelic professionalism, the inclusion of marginalized populations, and off-label use and marketing.

Featured Scholar